University of Liverpool - CJD breakthrough

March 12, 2009

The treatment of the human form of mad cow disease could be revolutionised by scientists at the University of Liverpool. They have determined the atomic structure of the binding between a brain protein and an antibody that could treat variant Creutzfeldt-Jakob disease (vCJD). vCJD is part of a family of neurodegenerative disorders known as prion diseases, which can develop when a naturally occurring protein called PrP comes into contact with infected prions. Antibodies that "stick" to PrP could treat vCJD.

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments